Differential effects of adjuvant EGFR tyrosine kinase inhibitors in patients with different stages of non-small-cell lung cancer after radical resection: an updated meta-analysis

PURPOSE: A survival improvement was achieved with adjuvant chemotherapy in non-small-cell lung cancer (NSCLC) patients, but its differential effects among patients with different stages remained controversial. This study aimed to compare the beneficial effects of adjuvant tyrosine kinase inhibitor (...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Manag Res
Asıl Yazarlar: Lu, Di, Wang, Zhizhi, Liu, Xiguang, Feng, Siyang, Dong, Xiaoying, Shi, Xiaoshun, Wang, He, Wu, Hua, Xiong, Gang, Wang, Haofei, Cai, Kaican
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450185/
https://ncbi.nlm.nih.gov/pubmed/31037035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S187940
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller